Phase 2 Clinical Study of Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma.
Phase of Trial: Phase II
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Letrozole (Primary)
- Indications Leiomyosarcoma
- Focus Therapeutic Use
- 07 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Mar 2014 Planned End Date changed from 1 Jun 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 01 Feb 2013 Planned End Date changed from 1 Feb 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.